Cargando…
Toward comprehensive imaging of oncolytic viroimmunotherapy
Oncolytic viruses infect, replicate in, and kill cancer cells, leaving normal cells unharmed; they also recruit and activate immune cells against tumor cells. While clinical indications for viroimmunotherapy are growing, barriers to widespread treatment remain. Ensuring real-time tracking of viral r...
Autores principales: | Chaurasiya, Shyambabu, Kim, Sang-In, O’Leary, Michael, Park, Anthony K., Lu, Jianming, Kang, Seonah, Zhang, Zhifang, Yang, Annie, Woo, Yanghee, Fong, Yuman, Warner, Susanne G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569424/ https://www.ncbi.nlm.nih.gov/pubmed/34786474 http://dx.doi.org/10.1016/j.omto.2021.06.010 |
Ejemplares similares
-
Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer
por: Kim, Sang-In, et al.
Publicado: (2022) -
Viroimmunotherapy for Colorectal Cancer: Clinical Studies
por: Chaurasiya, Shyambabu, et al.
Publicado: (2017) -
Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model
por: Chaurasiya, Shyambabu, et al.
Publicado: (2020) -
Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models
por: Kim, Sang-In, et al.
Publicado: (2020) -
An Oncolytic Poxvirus Encoding hNIS, Shows Antitumor Efficacy and Allows Tumor Imaging in a Liver Cancer Model
por: Chaurasiya, Shyambabu, et al.
Publicado: (2023)